Christopher Visioli
Director of Finance/CFO bei POPULATION HEALTH INVESTMENT CO., INC.
Profil
Herr Christopher Visioli ist Chief Financial Officer bei Population Health Investment Co., Inc. und Chief Financial & Accounting Officer bei The Medicines Co. Herr Visioli war zuvor als Senior Vice President-Financial Strategy bei The Medicines Co. beschäftigt. Er erhielt seinen Bachelor-Abschluss von der Cornell University und einen MBA von der Columbia Business School.
Aktive Positionen von Christopher Visioli
| Unternehmen | Position | Beginn |
|---|---|---|
| POPULATION HEALTH INVESTMENT CO., INC. | Director of Finance/CFO | 11.09.2020 |
Ehemalige bekannte Positionen von Christopher Visioli
| Unternehmen | Position | Ende |
|---|---|---|
| THE MEDICINES COMPANY | Director of Finance/CFO | 01.05.2020 |
Ausbildung von Christopher Visioli
| Cornell University | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
Population Health Investment Co., Inc.
 Population Health Investment Co., Inc. Financial ConglomeratesFinance Population Health Investment Co., Inc. operates as a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase and reorganization or similar business combination with one or more businesses. It intends to focus on companies in the healthcare industry such as the therapeutics sector. The company was founded by Clive A. Meanwell and Ian C. Read on September 11, 2020 and is headquartered in New York, NY. | Finance |
